Contact
Please use this form to send email to PR contact of this press release:
Human medicines European public assessment report (EPAR): Ponvory, ponesimod, Multiple Sclerosis, Relapsing-Remitting, Date of authorisation: 19/05/2021, Revision: 3, Status: Authorised
TO: